6949 — Pell Bio Med Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00- TWD21.51bn
- TWD21.31bn
- TWD19.63m
Annual cashflow statement for Pell Bio Med Technology Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -189 | -231 | -401 | -395 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 26.4 | 45.8 | 138 | 46.6 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 24.5 | -6.59 | 37.6 | 41.5 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -108 | -161 | -180 | -260 |
| Capital Expenditures | -14.5 | -8.49 | -16.5 | -264 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 98.4 | -542 | -403 | 168 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 83.9 | -551 | -420 | -95.5 |
| Financing Cash Flow Items | — | 15 | 0 | 110 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -5.23 | 769 | 595 | 615 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -29.2 | 56.6 | -4.73 | 260 |